Aromatase inhibitors as a therapeutic strategy for male prolactinoma resistant to dopamine agonists: a retrospective cohort study and literature review
Article in Journal of Endocrinological Investigation (November 2023)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
The Role of Aromatase Inhibitors in Male Prolactinoma
Article in Journal of Clinical Medicine (February 2023)
Letrozole Decreased Testosterone-Induced Cell Proliferation and Prolactin Secretion also Increased Apoptosis in MMQ and GH3 Rat Prolactinoma Cell Lines
Article in Molecular Neurobiology (January 2023)